trending Market Intelligence /marketintelligence/en/news-insights/trending/r2q_1npknxamvkcodmhyqw2 content esgSubNav
In This List

Brainstorm Cell Therapeutics appoints chief commercial officer

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Brainstorm Cell Therapeutics appoints chief commercial officer

New York-based biotechnology company Brainstorm Cell Therapeutics Inc. appointed Arturo Araya as chief commercial officer, effective Sept. 4.

Araya has served on Brainstorm's board since February 2017. He served as the global head of commercial for Novartis AG unit Novartis Pharmaceuticals Corp.'s cell and gene therapies unit until 2016.

Brainstorm develops stem cell treatments to treat diseases caused by degeneration of the nervous system.